Clinical Trial Update: Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating follicle-stimulating hormone to improve testicular development in men with hypogonadism (including Kallmann syndrome) was terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Kallmann Syndrome

Drugs mentioned

• follicle-stimulating hormone (follicle-stimulating hormone)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Hypogonadism, Kallmann Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2017-07-07